share_log

HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Maintains $8 Price Target

HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Maintains $8 Price Target

HC Wainwright & Co.重申对Plus Therapeutics的买入,维持8美元的目标股价
Benzinga ·  2023/08/15 07:05

HC Wainwright & Co. analyst Sean Lee reiterates Plus Therapeutics (NASDAQ:PSTV) with a Buy and maintains $8 price target.

HC Wainwright&Co.分析师肖恩·李重申了Plus Treateutics(纳斯达克:PSTV)的买入,并维持8美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发